IMP
Process View
positive regulation of cell substrate adhesion
Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cell substrate adhesion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FYN | FYN oncogene related to SRC, FGR, YES | 0.997 | ||
| EGFR | epidermal growth factor receptor | 0.996 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.989 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.985 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.978 | Human | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.975 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.954 | Human | |
| FN1 | fibronectin 1 | 0.943 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.938 | ||
| VEGFA | vascular endothelial growth factor A | 0.902 | ||
| S100A6 | S100 calcium binding protein A6 | 0.895 | Human | |
| FHL2 | four and a half LIM domains 2 | 0.869 | ||
| PXN | paxillin | 0.817 | Human | |
| S100A4 | S100 calcium binding protein A4 | 0.812 | Human | |
| MPDZ | multiple PDZ domain protein | 0.790 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.749 | ||
| S100A8 | S100 calcium binding protein A8 | 0.726 | Human | |
| SH3GL3 | SH3-domain GRB2-like 3 | 0.724 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.682 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.570 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.546 | ||
| S100A9 | S100 calcium binding protein A9 | 0.524 | Human | |
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.497 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.479 | ||
| CTGF | connective tissue growth factor | 0.423 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.420 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.348 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.340 | ||
| FLNA | filamin A, alpha | 0.331 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.316 | ||
| SMAD2 | SMAD family member 2 | 0.309 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.302 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.282 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.281 | Human | |
| NRP1 | neuropilin 1 | 0.278 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.272 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.271 | ||
| ANGPT2 | angiopoietin 2 | 0.269 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.269 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.256 | Human | |
| CCND1 | cyclin D1 | 0.238 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.233 | ||
| TSC2 | tuberous sclerosis 2 | 0.228 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.224 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.224 | Rat | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.209 | ||
| HP | haptoglobin | 0.208 | ||
| LAT | linker for activation of T cells | 0.187 | ||
| ANXA2 | annexin A2 | 0.183 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.177 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.169 | Human | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.166 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.164 | ||
| GHR | growth hormone receptor | 0.164 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.153 | ||
| EMP3 | epithelial membrane protein 3 | 0.153 | Human | |
| EFNA1 | ephrin-A1 | 0.144 | ||
| LMNA | lamin A/C | 0.140 | ||
| PARVA | parvin, alpha | 0.139 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.134 | ||
| CD63 | CD63 molecule | 0.129 | ||
| PRKCA | protein kinase C, alpha | 0.125 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.125 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.124 | ||
| ENG | endoglin | 0.121 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.114 | ||
| HOXA1 | homeobox A1 | 0.113 | ||
| LPXN | leupaxin | 0.112 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.112 | ||
| PGF | placental growth factor | 0.111 | Human | |
| AREG | amphiregulin | 0.109 | ||
| A2M | alpha-2-macroglobulin | 0.108 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.108 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.107 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.105 | Human | |
| ANGPT1 | angiopoietin 1 | 0.103 | ||
| ZNF746 | zinc finger protein 746 | 0.098 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.098 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.096 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.093 | ||
| MAPT | microtubule-associated protein tau | 0.091 | ||
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.086 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.086 | ||
| SNX9 | sorting nexin 9 | 0.086 | ||
| DSG2 | desmoglein 2 | 0.084 | ||
| S100B | S100 calcium binding protein B | 0.083 | Human | |
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.082 | ||
| APOC1 | apolipoprotein C-I | 0.081 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.081 | ||
| NCK2 | NCK adaptor protein 2 | 0.079 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.078 | ||
| DTNA | dystrobrevin, alpha | 0.077 | ||
| JUP | junction plakoglobin | 0.073 | ||
| VCL | vinculin | 0.070 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.070 | ||
| ANXA1 | annexin A1 | 0.068 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.068 | ||
| SH2D1A | SH2 domain containing 1A | 0.067 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.066 | ||
| FYB | FYN binding protein | 0.066 | ||
| AXL | AXL receptor tyrosine kinase | 0.064 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.064 | ||
| LDLR | low density lipoprotein receptor | 0.064 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.064 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.063 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.062 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.061 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.061 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.058 | ||
| CCND3 | cyclin D3 | 0.058 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.057 | ||
| EFNA5 | ephrin-A5 | 0.057 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.055 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.055 | ||
| MSN | moesin | 0.054 | ||
| KSR1 | kinase suppressor of ras 1 | 0.054 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.053 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.053 | ||
| TLN1 | talin 1 | 0.052 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.052 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.052 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.052 | ||
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.050 | ||
| EZR | ezrin | 0.049 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.049 | ||
| S100A1 | S100 calcium binding protein A1 | 0.049 | Human | |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.048 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.046 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.046 | ||
| ALB | albumin | 0.046 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.045 | ||
| KRT5 | keratin 5 | 0.045 | ||
| MAP2 | microtubule-associated protein 2 | 0.045 | ||
| VIM | vimentin | 0.044 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.043 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.043 | ||
| OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0.042 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.041 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.041 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.041 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.040 | ||
| THBS1 | thrombospondin 1 | 0.039 | Mouse | |
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.039 | ||
| ARHGAP32 | Rho GTPase activating protein 32 | 0.039 | ||
| S100A11 | S100 calcium binding protein A11 | 0.039 | Human | |
| ITGA6 | integrin, alpha 6 | 0.039 | ||
| RHOU | ras homolog gene family, member U | 0.039 | ||
| SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.038 | ||
| AHNAK | AHNAK nucleoprotein | 0.038 | ||
| DLC1 | deleted in liver cancer 1 | 0.038 | ||
| APOA1 | apolipoprotein A-I | 0.036 | ||
| TMEM108 | transmembrane protein 108 | 0.036 | ||
| ITGA7 | integrin, alpha 7 | 0.036 | ||
| CALD1 | caldesmon 1 | 0.035 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.035 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.035 | Human | |
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.035 | ||
| RHOA | ras homolog gene family, member A | 0.035 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.035 | ||
| CD34 | CD34 molecule | 0.035 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.035 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.035 | ||
| MYO6 | myosin VI | 0.034 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.034 | Human | |
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.033 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.033 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.033 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.033 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.033 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.032 | ||
| CD97 | CD97 molecule | 0.032 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.032 | ||
| FERMT2 | fermitin family member 2 | 0.032 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.032 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.032 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.031 | ||
| YAP1 | Yes-associated protein 1 | 0.031 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.031 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.031 | ||
| PRKCQ | protein kinase C, theta | 0.031 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.030 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.030 | ||
| PARVB | parvin, beta | 0.030 | ||
| PTRF | polymerase I and transcript release factor | 0.030 | ||
| TMSB10 | thymosin beta 10 | 0.029 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.029 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.029 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.029 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.029 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.029 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.028 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.027 | ||
| AXIN1 | axin 1 | 0.027 | ||
| CD9 | CD9 molecule | 0.027 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.027 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.027 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.027 | Yeast | |
| VCAM1 | vascular cell adhesion molecule 1 | 0.027 | ||
| VCAN | versican | 0.026 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.026 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.026 | Human | |
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.026 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.026 | ||
| UTRN | utrophin | 0.026 | ||
| DMD | dystrophin | 0.025 | Human Mouse | |
| MPRIP | myosin phosphatase Rho interacting protein | 0.025 | ||
| TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 0.025 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.025 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.025 | Human | |
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.025 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.025 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.025 | Human | |
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.025 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.025 | ||
| STC1 | stanniocalcin 1 | 0.025 | ||
| PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.025 | ||
| VEGFC | vascular endothelial growth factor C | 0.024 | Human Mouse | |
| ITGA8 | integrin, alpha 8 | 0.024 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.024 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.024 | ||
| NID1 | nidogen 1 | 0.024 | Mouse | |
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.023 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.023 | ||
| APOC3 | apolipoprotein C-III | 0.023 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.023 | ||
| DTNB | dystrobrevin, beta | 0.023 | ||
| OSMR | oncostatin M receptor | 0.023 | ||
| PDGFC | platelet derived growth factor C | 0.023 | ||
| CCND2 | cyclin D2 | 0.023 | ||
| S100A2 | S100 calcium binding protein A2 | 0.023 | Human | |
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.023 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.023 | ||
| POSTN | periostin, osteoblast specific factor | 0.022 | ||
| PRKCE | protein kinase C, epsilon | 0.022 | Mouse | |
| ANXA5 | annexin A5 | 0.022 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.022 | ||
| DCN | decorin | 0.022 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.022 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.022 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.022 | ||
| SIRPA | signal-regulatory protein alpha | 0.022 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.022 | ||
| ZNF426 | zinc finger protein 426 | 0.022 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.022 | Human | |
| DSP | desmoplakin | 0.022 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.022 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.021 | ||
| APOA2 | apolipoprotein A-II | 0.021 | ||
| AMOTL2 | angiomotin like 2 | 0.021 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.021 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.021 | Zebrafish | |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.021 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.021 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.021 | ||
| PLTP | phospholipid transfer protein | 0.021 | ||
| TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.020 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.020 | ||
| ILK | integrin-linked kinase | 0.020 | Rat | |
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.020 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.020 | ||
| S100P | S100 calcium binding protein P | 0.020 | Human | |
| NCF1 | neutrophil cytosolic factor 1 | 0.020 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.020 | Human | |
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.020 | ||
| FBN1 | fibrillin 1 | 0.020 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.020 | ||
| EPHA3 | EPH receptor A3 | 0.020 | Human | |
| ITGB5 | integrin, beta 5 | 0.020 | ||
| NNMT | nicotinamide N-methyltransferase | 0.020 | ||
| AR | androgen receptor | 0.020 | ||
| EMCN | endomucin | 0.019 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.019 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.019 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.019 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.019 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.019 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.019 | ||
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.018 | ||
| CTDSP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | 0.018 | ||
| KIAA1949 | KIAA1949 | 0.018 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.018 | ||
| FGA | fibrinogen alpha chain | 0.018 | ||
| EMP1 | epithelial membrane protein 1 | 0.018 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.018 | ||
| HECTD3 | HECT domain containing 3 | 0.018 | ||
| ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) | 0.017 | ||
| NRP2 | neuropilin 2 | 0.017 | ||
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.017 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.017 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.017 | ||
| SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) | 0.017 | ||
| CTTN | cortactin | 0.017 | ||
| LIMK1 | LIM domain kinase 1 | 0.017 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.017 | Human | |
| PRKCSH | protein kinase C substrate 80K-H | 0.017 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.017 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.017 | ||
| ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 0.016 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.016 | ||
| SSTR3 | somatostatin receptor 3 | 0.016 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.016 | ||
| TCF4 | transcription factor 4 | 0.016 | ||
| CREBBP | CREB binding protein | 0.016 | ||
| RHOC | ras homolog gene family, member C | 0.016 | ||
| RASGEF1C | RasGEF domain family, member 1C | 0.016 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.015 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.015 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.015 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.015 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.015 | ||
| MYCT1 | myc target 1 | 0.015 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.015 | ||
| APOC2 | apolipoprotein C-II | 0.015 | ||
| MMRN2 | multimerin 2 | 0.015 | ||
| NCK1 | NCK adaptor protein 1 | 0.015 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.015 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.015 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.015 | ||
| INHBA | inhibin, beta A | 0.015 | ||
| MCAM | melanoma cell adhesion molecule | 0.015 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.014 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.014 | ||
| ATM | ataxia telangiectasia mutated | 0.014 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.014 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.014 | ||
| GPSM3 | G-protein signaling modulator 3 | 0.014 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.014 | ||
| SRI | sorcin | 0.014 | ||
| EFNB2 | ephrin-B2 | 0.014 | ||
| SPHK1 | sphingosine kinase 1 | 0.014 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.014 | Human | |
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.014 | ||
| ARVCF | armadillo repeat gene deleted in velocardiofacial syndrome | 0.014 | ||
| S100A12 | S100 calcium binding protein A12 | 0.014 | Human | |
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.014 | ||
| CHRD | chordin | 0.014 | ||
| CD248 | CD248 molecule, endosialin | 0.014 | ||
| FRMD5 | FERM domain containing 5 | 0.014 | ||
| ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | 0.014 | ||
| MTMR4 | myotubularin related protein 4 | 0.014 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.014 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.014 | ||
| STAB1 | stabilin 1 | 0.014 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.014 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.014 | ||
| TMEM47 | transmembrane protein 47 | 0.014 | ||
| CALCRL | calcitonin receptor-like | 0.013 | ||
| PLAT | plasminogen activator, tissue | 0.013 | ||
| EPHA7 | EPH receptor A7 | 0.013 | Human | |
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.013 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.013 | ||
| LAMA5 | laminin, alpha 5 | 0.013 | ||
| LPL | lipoprotein lipase | 0.013 | ||
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.013 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.013 | ||
| KRT1 | keratin 1 | 0.013 | ||
| TNC | tenascin C | 0.013 | ||
| PRRX1 | paired related homeobox 1 | 0.013 | ||
| PLEKHA2 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 | 0.013 | ||
| FOXF2 | forkhead box F2 | 0.013 | ||
| SFN | stratifin | 0.013 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.013 | ||
| EPHB4 | EPH receptor B4 | 0.013 | Human | |
| EDN1 | endothelin 1 | 0.013 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.013 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.013 | ||
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.013 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.013 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.013 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.013 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.013 | ||
| ABI3BP | ABI family, member 3 (NESH) binding protein | 0.013 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.013 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.013 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.013 | ||
| KIAA1033 | KIAA1033 | 0.013 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.013 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.013 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.012 | ||
| CORO1A | coronin, actin binding protein, 1A | 0.012 | ||
| NFIB | nuclear factor I/B | 0.012 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.012 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.012 | ||
| DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.012 | ||
| DOCK8 | dedicator of cytokinesis 8 | 0.012 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.012 | ||
| BGN | biglycan | 0.012 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.012 | ||
| SH2B3 | SH2B adaptor protein 3 | 0.012 | ||
| NUMB | numb homolog (Drosophila) | 0.012 | ||
| TGFA | transforming growth factor, alpha | 0.012 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.012 | ||
| LOX | lysyl oxidase | 0.012 | ||
| CSRP1 | cysteine and glycine-rich protein 1 | 0.012 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.012 | ||
| LEPR | leptin receptor | 0.012 | ||
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.012 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.012 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.012 | ||
| CD93 | CD93 molecule | 0.012 | ||
| COL12A1 | collagen, type XII, alpha 1 | 0.012 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.012 | ||
| EDNRA | endothelin receptor type A | 0.012 | ||
| YY1 | YY1 transcription factor | 0.012 | ||
| PKP3 | plakophilin 3 | 0.012 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.012 | Human | |
| GPR116 | G protein-coupled receptor 116 | 0.012 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.012 | ||
| CNN2 | calponin 2 | 0.011 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.011 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.011 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.011 | ||
| THBD | thrombomodulin | 0.011 | ||
| ECSIT | ECSIT homolog (Drosophila) | 0.011 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.011 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.011 | ||
| TAGLN | transgelin | 0.011 | ||
| THY1 | Thy-1 cell surface antigen | 0.011 | ||
| CRIP1 | cysteine-rich protein 1 (intestinal) | 0.011 | ||
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.011 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.011 | ||
| CRYAB | crystallin, alpha B | 0.011 | ||
| EPHA2 | EPH receptor A2 | 0.011 | Human | |
| POM121 | POM121 membrane glycoprotein | 0.011 | ||
| STK10 | serine/threonine kinase 10 | 0.011 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.011 | ||
| EML3 | echinoderm microtubule associated protein like 3 | 0.011 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.011 | ||
| PMP22 | peripheral myelin protein 22 | 0.011 | Human | |
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.011 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.011 | ||
| NCL | nucleolin | 0.011 | ||
| FBLN1 | fibulin 1 | 0.011 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.011 | ||
| SYK | spleen tyrosine kinase | 0.011 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | Human | |
| LAMC2 | laminin, gamma 2 | 0.011 | ||
| PRKCD | protein kinase C, delta | 0.011 | ||
| ZNF331 | zinc finger protein 331 | 0.011 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.011 | ||
| FRZB | frizzled-related protein | 0.011 | ||
| ATXN1 | ataxin 1 | 0.011 | ||
| PDE10A | phosphodiesterase 10A | 0.011 | ||
| MYO9B | myosin IXB | 0.010 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.010 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.010 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.010 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.010 | Human | |
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.010 | ||
| CSTA | cystatin A (stefin A) | 0.010 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.010 | ||
| PLEK | pleckstrin | 0.010 | ||
| FGL2 | fibrinogen-like 2 | 0.010 | ||
| TGM1 | transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) | 0.010 | ||
| TPM1 | tropomyosin 1 (alpha) | 0.010 | ||
| F11R | F11 receptor | 0.010 | ||
| ARHGEF2 | Rho/Rac guanine nucleotide exchange factor (GEF) 2 | 0.010 | ||
| ICAM3 | intercellular adhesion molecule 3 | 0.010 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.010 | ||
| KIAA1462 | KIAA1462 | 0.010 | ||
| S100A10 | S100 calcium binding protein A10 | 0.010 |